Related references
Note: Only part of the references are listed.Tim-3 Blockade Elicits Potent Anti-Multiple Myeloma Immunity of Natural Killer Cells
Wen Jiang et al.
FRONTIERS IN ONCOLOGY (2022)
Natural killer cells activity against multiple myeloma cells is modulated by osteoblast-induced IL-6 and IL-10 production
Christopher Uhl et al.
HELIYON (2022)
LGK974 suppresses lipopolysaccharide-induced endotoxemia in mice by modulating the crosstalk between the Wnt/β-catenin and NF-κB pathways
Jaewoong Jang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2021)
NF-κB c-Rel Is Dispensable for the Development but Is Required for the Cytotoxic Function of NK Cells
Yorleny Vicioso et al.
FRONTIERS IN IMMUNOLOGY (2021)
Crosstalk between Wnt/β-catenin signaling and NF-κB signaling contributes to apical periodontitis
Xiaoyue Guan et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Wnt-C59 inhibits proinflammatory cytokine expression by reducing the interaction between β-catenin and NF-κB in LPS-stimulated epithelial and macrophage cells
Jaewoong Jang et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2021)
Multiple myeloma: 2020 update on diagnosis, risk-stratification and management
S. Vincent Rajkumar
AMERICAN JOURNAL OF HEMATOLOGY (2020)
GSK-3β in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer
Jintao Lin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)
Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy?
Aviad Ben-Shmuel et al.
FRONTIERS IN IMMUNOLOGY (2020)
The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment
Giuseppa Augello et al.
CELLS (2020)
Roles of IFN-γ in tumor progression and regression: a review
Dragica Jorgovanovic et al.
BIOMARKER RESEARCH (2020)
Cytokine profile in multiple myeloma
Shivali Jasrotia et al.
CYTOKINE (2020)
Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses
Ilyas Sahin et al.
CANCER BIOLOGY & THERAPY (2019)
Mechanisms of natural killer cell-mediated cellular cytotoxicity
Isabel Prager et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
Single Degranulations in NK Cells Can Mediate Target Cell Killing
Lavesh A. Gwalani et al.
JOURNAL OF IMMUNOLOGY (2018)
GSK3β modulates NF-κB activation and RelB degradation through site-specific phosphorylation of BCL10
Ali Abd-Ellah et al.
SCIENTIFIC REPORTS (2018)
MiR-26a enhances invasive capacity by suppressing GSK3β in human lung cancer cells
Gaoyang Lin et al.
EXPERIMENTAL CELL RESEARCH (2017)
Multifaceted Roles of GSK-3 in Cancer and Autophagy-Related Diseases
Romina Mancinelli et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
MicroRNA-23b functions as an oncogene and activates AKT/GSK3β/β-catenin signaling by targeting ST7L in hepatocellular carcinoma
Likun Zhuang et al.
CELL DEATH & DISEASE (2017)
GSK3 Inhibition Drives Maturation of NK Cells and Enhances Their Antitumor Activity
Frank Cichocki et al.
CANCER RESEARCH (2017)
Phase 1 clinical trial of adoptive immunotherapy using off-the-shelf activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia
Michael Boyiadzis et al.
CYTOTHERAPY (2017)
β-Catenin overexpression causes an increase in inflammatory cytokines and NF-κB activation in cardiomyocytes
J. C. Lin et al.
CELLULAR AND MOLECULAR BIOLOGY (2017)
MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway
Hongyu Shen et al.
GENE (2016)
Rab27A mediated by NF-κB promotes the stemness of colon cancer cells via up-regulation of cytokine secretion
Feixue Feng et al.
ONCOTARGET (2016)
PD1 blockade enhances cytotoxicity of in vitro expanded natural killer cells towards myeloma cells
Yanan Guo et al.
ONCOTARGET (2016)
GSK-3β controls NF-kappaB activity via IKKγ/NEMO
Senad Medunjanin et al.
SCIENTIFIC REPORTS (2016)
NK cell function triggered by multiple activating receptors is negatively regulated by glycogen synthase kinase-3β
Hyung-Joon Kwon et al.
CELLULAR SIGNALLING (2015)
Ex Vivo-expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo in High-risk Relapsed Multiple Myeloma Patients
Susann Szmania et al.
JOURNAL OF IMMUNOTHERAPY (2015)
NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma
Cinzia Fionda et al.
BIOMED RESEARCH INTERNATIONAL (2015)
KIR genotype distribution among patients with multiplemyeloma: Higher prevalence of KIR 2DS4 and KIR 2DS5 genes
R. Hoteit et al.
META GENE (2014)
Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack
Jamie A. Lopez et al.
BLOOD (2013)
Regulation of vesicular trafficking and leukocyte function by Rab27 GTPases and their effectors
Sergio Daniel Catz
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
NF-κB, the first quarter-century: remarkable progress and outstanding questions
Matthew S. Hayden et al.
GENES & DEVELOPMENT (2012)
IκBζ augments IL-12-and IL-18-mediated IFN-γ production in human NK cells
Yashaswini Kannan et al.
BLOOD (2011)
Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation
Jumei Shi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial
S. Arai et al.
CYTOTHERAPY (2008)
Glycogen synthase kinase 3: A key regulator of cellular fate
J. E. Forde et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Glycogen synthase kinase-3 - An overview of an over-achieving protein kinase
Lisa Kockeritz et al.
CURRENT DRUG TARGETS (2006)
Wnt signaling: complexity at the surface
KM Cadigan et al.
JOURNAL OF CELL SCIENCE (2006)
Glycogen synthase kinase 3β functions to specify gene-specific, NF-κB-dependent transcription
KA Steinbrecher et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Share Paper
